'[T]he quantity of drugs attributed to a defendant need not be foreseeable to him when he personally participates, in a direct way, in a jointly undertaken drug transaction,' pursuant to U.S. v. Chalarca, a 1996 decision of the U.S. Court of Appeals for the 2nd Circuit.
Font Size: 
U.S. v. Garcia
U.S. Court of Appeals for the 2nd Circuit
May 9, 2012
This article requires premium access
This article requires premium access to Connecticut Law Tribune. Please sign in or subscribe to read the full text.
